Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceutics|February 26, 2022
Design Principles Governing the Development of Theranostic Anticancer Agents and Their Nanoformulations with Photoacoustic PropertiesStavroula G Kyrkou, Eirinaios I Vrettos, Dimitris Gorpas, et al.
Frontiers in Immunology|September 23, 2024
Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the diseaseNatalija Jonić, Ivan Koprivica, Stavroula G Kyrkou, et al.
European Journal of Medicinal Chemistry|March 22, 2025
Discovery of first-in-class human glycolate oxidase near infrared molecular rotor inhibitors (NIRGOi)Sabrina R Mackinnon, Christos M Chatzigiannis, Stavroula G Kyrkou, et al.
Cancers|November 9, 2024
Design Principles and Applications of Fluorescent Kinase Inhibitors for Simultaneous Cancer Bioimaging and TherapyAb Majeed Ganai, Eirinaios I Vrettos, Stavroula G Kyrkou, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Development of AGT-7: An Innovative 99mTc-Labeled Theranostic Platform for Glioblastoma Imaging and TherapyStavroula G Kyrkou, Vasileios-Panagiotis Bistas, Evangelia-Alexandra Salvanou, et al.
Molecules (Basel, Switzerland)|July 13, 2024
Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory CellsNatalija Jonić, Ivan Koprivica, Christos M Chatzigiannis, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 28, 2024
A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to GemcitabineEirinaios Ι Vrettos, Stavroula G Kyrkou, Vasiliki Zoi, et al.
Pageof 1